These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 35316688)

  • 1. Factors supporting substance use improvement for Black Americans: A population health observational study.
    Sahker E; Pro G; Sakata M; Poudyal H; Jordan A; Furukawa TA
    Drug Alcohol Depend; 2022 May; 234():109405. PubMed ID: 35316688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance use improvement depends on Race/Ethnicity: Outpatient treatment disparities observed in a large US national sample.
    Sahker E; Pro G; Sakata M; Furukawa TA
    Drug Alcohol Depend; 2020 Aug; 213():108087. PubMed ID: 32492601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Employment recovery capital in the treatment of substance use disorders: Six-month follow-up observations.
    Sahker E; Ali SR; Arndt S
    Drug Alcohol Depend; 2019 Dec; 205():107624. PubMed ID: 31645013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of substance use disorder treatment and mutual support group participation among Black women across the criminal legal spectrum: A latent class approach.
    Oser CB; Moody MD; Hansen AC; Stevens-Watkins D; Staton M; Bunting AM
    Drug Alcohol Depend; 2024 Jul; 260():111326. PubMed ID: 38733734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial disparities in linkage to care among patients with substance use disorders.
    Webb CP; Huecker M; Shreffler J; McKinley BS; Khan AM; Shaw I
    J Subst Abuse Treat; 2022 Jun; 137():108691. PubMed ID: 34955317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residential and outpatient treatment completion for substance use disorders in the U.S.: Moderation analysis by demographics and drug of choice.
    Stahler GJ; Mennis J; DuCette JP
    Addict Behav; 2016 Jul; 58():129-35. PubMed ID: 26925821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and Ethnic Disparities in Outpatient Substance Use Disorder Treatment Episode Completion for Different Substances.
    Mennis J; Stahler GJ
    J Subst Abuse Treat; 2016 Apr; 63():25-33. PubMed ID: 26818489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Client and program characteristics associated with wait time to substance abuse treatment entry.
    Andrews CM; Shin HC; Marsh JC; Cao D
    Am J Drug Alcohol Abuse; 2013 Jan; 39(1):61-8. PubMed ID: 22783953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race/ethnicity and quality indicators for outpatient treatment for substance use disorders.
    Acevedo A; Garnick D; Ritter G; Horgan C; Lundgren L
    Am J Addict; 2015 Sep; 24(6):523-31. PubMed ID: 26179892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How the states stack up: disparities in substance abuse outpatient treatment completion rates for minorities.
    Arndt S; Acion L; White K
    Drug Alcohol Depend; 2013 Oct; 132(3):547-54. PubMed ID: 23664124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities in completion of substance abuse treatment between and within racial and ethnic groups.
    Guerrero EG; Marsh JC; Duan L; Oh C; Perron B; Lee B
    Health Serv Res; 2013 Aug; 48(4):1450-67. PubMed ID: 23350871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Program Capacity to Deliver Prevention Services to Children of Adult Clients Receiving Substance Use Disorder Treatment.
    Guerrero EG; Padwa H; Serret V; Rico M; Hunter S; Gelberg L
    J Prim Prev; 2019 Jun; 40(3):343-355. PubMed ID: 31093817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of spiritual well-being and social support on substance use treatment outcomes within a sample of predominantly Black/African American adults.
    Kane L; Benson K; Stewart ZJ; Daughters SB
    J Subst Use Addict Treat; 2024 Mar; 158():209238. PubMed ID: 38061630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial disparities in use of non-emergency outpatient care by Medicaid-eligible adults after release from prison: Wisconsin, 2015-2017.
    Hochstatter KR; Akhtar WZ; El-Bassel N; Westergaard RP; Burns ME
    J Subst Abuse Treat; 2021 Jul; 126():108484. PubMed ID: 34052054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating racial disparity in referral source and successful completion of substance abuse treatment.
    Sahker E; Toussaint MN; Ramirez M; Ali SR; Arndt S
    Addict Behav; 2015 Sep; 48():25-9. PubMed ID: 25935719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with patient-reported experiences and outcomes of substance use disorder treatment in Cape Town, South Africa.
    Myers B; Koch JR; Johnson K; Harker N
    Addict Sci Clin Pract; 2022 Feb; 17(1):8. PubMed ID: 35109915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homelessness and publicly funded substance use disorder treatment in California, 2016-2019: Analysis of treatment needs, level of care placement, and outcomes.
    Padwa H; Bass B; Urada D
    J Subst Abuse Treat; 2022 Jun; 137():108711. PubMed ID: 35012791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of value-based purchasing for substance use treatment engagement and retention.
    Reif S; Stewart MT; Torres ME; Davis MT; Dana BM; Ritter GA
    J Subst Abuse Treat; 2021 Mar; 122():108217. PubMed ID: 33509415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of outpatient substance use disorder treatment length-of-stay and completion: the case of a treatment program in the southeast U.S.
    Baird A; Cheng Y; Xia Y
    Sci Rep; 2023 Aug; 13(1):13961. PubMed ID: 37633996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.